Mots-clés
 > MYOBASE > SANTE > médecine > diagnostic > procédé diagnostique > diagnostic biochimique > diagnostic moléculaire
diagnostic moléculaireSynonyme(s)molecular diagnosis |
Documents disponibles dans cette catégorie (500)
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de rechercheEtendre la recherche sur niveau(x) vers le bas
Article
Prior TW ; Leach ME ; Finanger E | 3/12/2020Initial Posting: February 24, 2000; Last Revision: December 3, 2020. Clinical characteristics. Spinal muscular atrophy (SMA) is characterized by muscle weakness and atrophy resulting from progressive degeneration and irreversible loss of t[...]Article
Ferreira C ; Pierre G ; Thompson R ; Vernon H | 09/07/2020nitial Posting: October 9, 2014; Last Update: July 9, 2020. Clinical characteristics. Barth syndrome is characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, prepubertal growth delay, and distinctive facial ges[...]Article
Bird TD | 14/05/2020Initial Posting: September 28, 1998; Last Revision: May 14, 2020. The purpose of this overview is to increase the awareness of clinicians regarding Charcot-Marie-Tooth (CMT) hereditary neuropathy, its causes, and its management. The follow[...]Brève
Urtizberea JA, Auteur | 20/02/2020Article
Shchagina OA ; Milovidova TB ; Murtazina AF ; Rudenskaya GE ; Nikitin SS ; Dadali EL ; Polyakov AV | Netherlands | 02/2020Article
Rosenberg H ; Sambuughin N ; Riazi S ; Dirksen R | 16/01/2020Initial Posting: December 19, 2003; Last Update: January 16, 2020. Clinical characteristics. Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeleta[...]Article
Forrester N ; Rattihalli R ; Horvath R ; Maggi L ; Manzur A ; Fuller G ; Gutowski N ; Rankin J ; Dick D ; Buxton C ; Greenslade M ; Majumdar A | Netherlands | 2020Article
Cortese A ; Wilcox JE ; Polke JM ; Poh R ; Skorupinska M ; Rossor AM ; Laura M ; Tomaselli PJ ; Houlden H ; Shy ME ; Reilly MM | United States | 01/2020
Brève
Urtizberea JA, Auteur | 09/12/2019Article
Mortreux J ; Bacquet J ; Boyer A ; Alazard E ; Bellance R ; Giguet-Valard AG ; Cerino M ; Krahn M ; Audic F ; Chabrol B ; Laugel V ; Desvignes JP ; Béroud C ; Nguyen K ; Verschueren A ; Lévy N ; Attarian S ; Delague V ; Missirian C ; Bonello-Palot N | England | 12/2019Article
Article
Labrador E ; Weinstein DA | 27/11/2019Initial Posting: April 23, 2009; Last Update: November 27, 2019. Clinical characteristics. Glycogen storage disease type VI (GSD VI) is a disorder of glycogenolysis caused by deficiency of hepatic glycogen phosphorylase. This critical enzy[...]Article
Article
Bonne G ; Leturcq F ; Ben Yaou R | 15/08/2019Initial Posting: September 29, 2004; Last Update: August 15, 2019. Clinical characteristics. Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progr[...]Article
Neurology. Genetics, 5, 5. Next-generation sequencing approach to hyperCKemia: A 2-year cohort study
Rubegni A, Auteur ; Malandrini A ; Dosi C ; Astrea G ; Baldacci J ; Battisti C ; Bertocci G ; Donati MA ; Dotti MT ; Federico A ; Giannini F ; Grosso S ; Guerrini R ; Lenzi S ; Maioli MA ; Melani F ; Mercuri E ; Sacchini M ; Salvatore S ; Siciliano G ; Tolomeo D ; Tonin P ; Volpi N ; Santorelli FM ; Cassandrini D | United States | 08/2019Article
Saito K | 03/07/2019Initial Posting: January 26, 2006; Last Update: July 3, 2019. Clinical characteristics. Fukuyama congenital muscular dystrophy (FCMD) is characterized by hypotonia, symmetric generalized muscle weakness, and CNS migration disturbances that[...]Article
Initial Posting: August 5, 2008; Last Update: June 6, 2019. The purpose of this overview is to increase clinician awareness of the genetic basis of hypertrophic cardiomyopathy (HCM) and the benefits of early diagnosis and management to indivi[...]Article
Leslie ND ; Valencia CA ; Strauss AW ; Zhang K | 23/05/2019Initial Posting: May 28, 2009; Last Revision: May 23, 2019. Clinical characteristics. Deficiency of very long-chain acyl-CoA dehydrogenase (VLCAD), which catalyzes the initial step of mitochondrial beta-oxidation of long-chain fatty acids [...]
Brève
Samira Conchon, Auteur | 19/03/2019
Brève
Samira Conchon, Auteur | 05/03/2019Article
Wieser T | 03/01/2019Initial Posting: August 27, 2004; Last Revision: January 3, 2019. Clinical characteristics. Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal n[...]Article
El-Hattab AW ; Almannai M ; Scaglia F | 29/11/2018Initial Posting: February 27, 2001; Last Update: November 29, 2018. Clinical characteristics. MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) is a multisystem disorder with protean manifestations. The vast [...]Article
Herbert M ; Goldstein JL ; Rehder C ; Austin S ; Kishnani PS ; Bali DS | 01/11/2018Initial Posting: May 31, 2011; Last Update: November 1, 2018. Clinical characteristics. Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, whi[...]Article
Hershberger RE ; Morales A | 23/08/2018Initial Posting: July 27, 2007; Last Update: August 23, 2018. The purpose of this overview is to increase clinician awareness of the genetic basis of dilated cardiomyopathy (DCM) and the benefits of early diagnosis and management to individua[...]Article
Dowling JJ ; Lawlor MW ; Das S | 23/08/2018Initial Posting: February 25, 2002; Last Update: August 23, 2018. Clinical characteristics. X-linked myotubular myopathy (X-MTM), also known as myotubular myopathy (MTM), is characterized by muscle weakness that ranges from severe to mild. [...]
